Muzaffar Qazilbash
@Transplant_Doc
Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own
04-07-2010 03:26:14
19,9K Tweets
7,0K Followers
237 Following
VOD/SOS is more common (16.8%) in patients </=25 years than >25 (3.8%) after alloHCT. Higher DRI and multiple prior lines of Rx are other risk factors #bmtsm
MD Anderson Cancer Center
Richard Champlin
Dr. Elizabeth Shpall
Blood Advances ashpublications.org/bloodadvances/…